192
Participants
Start Date
November 30, 2014
Primary Completion Date
July 31, 2015
Study Completion Date
July 31, 2015
5μg/ml ESAT6-CFP10 in left arm and TB-PPD in right arm
TB subjects and non-TB subjects with lung disease inject 5μg/ml ESAT6-CFP10 in left arm and TB-PPD in right arm respectively. Two drug must use at the same person and different arm.
5μg/ml ESAT6-CFP10 in right arm and TB-PPD in left arm
TB subjects and non-TB subjects with lung disease inject 5μg/ml ESAT6-CFP10 in right arm and TB-PPD in left arm respectively. Two drug must use at the same person and different arm.
10μg/ml ESAT6-CFP10 in left arm and TB-PPD in right arm
TB subjects and non-TB subjects with lung disease inject 10μg/ml ESAT6-CFP10 in left arm and TB-PPD in right arm respectively. Two drug must use at the same person and different arm.
10μg/ml ESAT6-CFP10 in right arm and TB-PPD in left arm
TB subjects and non-TB subjects with lung disease inject 10μg/ml ESAT6-CFP10 in right arm and TB-PPD in left arm respectively. Two drug must use at the same person and different arm.
Shanghai Public Health Clinical Center
OTHER_GOV
Tianjin Haihe Hospital
OTHER
Wuhan Institute for Tuberculosis Control
OTHER
Proswell Medical Corporation
INDUSTRY
Air Force Military Medical University, China
OTHER
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
INDUSTRY